Cargando…

Possible inhibition of GM-CSF production by SARS-CoV-2 spike-based vaccines

A SARS-like coronavirus 2 (SARS-CoV-2) has caused a pandemic Coronavirus Disease 2019 (COVID-19) that killed more than 3.3 million people worldwide. Like the SARS-CoV, SARS-CoV-2 also employs a receptor-binding motif (RBM) of its spike protein to bind a host receptor, the angiotensin-converting enzy...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Jianhua, Wang, Ping, Tracey, Kevin J., Wang, Haichao
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2021
Materias:	Perspective
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8140578/ https://www.ncbi.nlm.nih.gov/pubmed/34022793 http://dx.doi.org/10.1186/s10020-021-00313-3

Ejemplares similares

Monoclonal Antibodies Capable of Binding SARS-CoV-2 Spike Protein Receptor Binding Motif Specifically Prevent GM-CSF Induction.
por: Qiang, Xiaoling, et al.
Publicado: (2020)

Monoclonal antibodies capable of binding SARS‐CoV‐2 spike protein receptor‐binding motif specifically prevent GM‐CSF induction
por: Qiang, Xiaoling, et al.
Publicado: (2021)

GM-CSF-based treatments in COVID-19: reconciling opposing therapeutic approaches
por: Lang, Frederick M., et al.
Publicado: (2020)

mRNA Vaccines: Possible Tools to Combat SARS-CoV-2
por: Yi, Changhua, et al.
Publicado: (2020)

Development of Dendritic Cells from GM-CSF(-/-) Mice in vitro : GM-CSF Enhances Production and Survival of Cells
por: Ni, Keping, et al.
Publicado: (2001)

GM-CSF in inflammation
por: Hamilton, John A.
Publicado: (2019)

The Emergence of the Spike Furin Cleavage Site in SARS-CoV-2
por: Chan, Yujia Alina, et al.
Publicado: (2021)

G-CSF and GM-CSF in clinical trials.
por: Antman, K. H.
Publicado: (1990)

Recombinant GM-CSF for diseases of GM-CSF insufficiency: Correcting dysfunctional mononuclear phagocyte disorders
por: Lazarus, Hillard M., et al.
Publicado: (2023)

Identification of possible binding modes of SARS-CoV-2 spike N-terminal domain for ganglioside GM1
por: Das, Tanushree, et al.
Publicado: (2023)

Local Sustained GM-CSF Delivery by Genetically Engineered Encapsulated Cells Enhanced Both Cellular and Humoral SARS-CoV-2 Spike-Specific Immune Response in an Experimental Murine Spike DNA Vaccination Model
por: Vernet, Rémi, et al.
Publicado: (2021)

Moving beyond the GM Debate
por: Leyser, Ottoline
Publicado: (2014)

GM-CSF Signalling Boosts Dramatically IL-1Production
por: Khameneh, Hanif Javanmard, et al.
Publicado: (2011)

A role for G-CSF and GM-CSF in nonmyeloid cancers
por: Aliper, Alexander M, et al.
Publicado: (2014)

GM-CSF-Dependent Inflammatory Pathways
por: Hamilton, John A.
Publicado: (2019)

GM-CSF: A Promising Target in Inflammation and Autoimmunity
por: Lee, Kevin M C, et al.
Publicado: (2020)

Effect of AcHERV-GmCSF as an Influenza Virus Vaccine Adjuvant
por: Choi, Hyo Jung, et al.
Publicado: (2015)

Higher binding affinity of furin for SARS-CoV-2 spike (S) protein D614G mutant could be associated with higher SARS-CoV-2 infectivity
por: Mohammad, Anwar, et al.
Publicado: (2021)

The Possible Role of Glucose-6-Phosphate Dehydrogenase in the SARS-CoV-2 Infection
por: Pérez-Torres, Israel, et al.
Publicado: (2022)

Development of Membrane-Bound GM-CSF and IL-18 as an Effective Tumor Vaccine
por: Huang, Chien-Chiao, et al.
Publicado: (2015)

iNKT Cell Production of GM-CSF Controls Mycobacterium tuberculosis
por: Rothchild, Alissa C., et al.
Publicado: (2014)

T Cell Production of GM-CSF Protects the Host during Experimental Tuberculosis
por: Robinson, Richard T.
Publicado: (2017)

Response to Treatment with TNFα Inhibitors in Rheumatoid Arthritis Is Associated with High Levels of GM-CSF and GM-CSF(+) T Lymphocytes
por: Bystrom, Jonas, et al.
Publicado: (2017)

Construction of Recombinant Human GM-CSF and GM-CSF-ApoA-I Fusion Protein and Evaluation of Their Biological Activity
por: Pykhtina, Mariya, et al.
Publicado: (2021)

Cell fusion as a link between the SARS-CoV-2 spike protein, COVID-19 complications, and vaccine side effects
por: Lazebnik, Yuri
Publicado: (2021)

Hypothesis: Possible influence of antivector immunity and SARS‐CoV‐2 variants on efficacy of ChAdOx1 nCoV‐19 vaccine
por: Zamai, Loris, et al.
Publicado: (2021)

Approaches and Challenges in SARS-CoV-2 Vaccine Development
por: Dagotto, Gabriel, et al.
Publicado: (2020)

SARS-CoV-2 Vaccines in Patients With Multiple Myeloma
por: Gavriatopoulou, Maria, et al.
Publicado: (2021)

Adapting Serosurveys for the SARS-CoV-2 Vaccine Era
por: Duarte, Nathan, et al.
Publicado: (2021)

CSF1R Inhibition Combined with GM-CSF Reprograms Macrophages and Disrupts Protumoral Interplays with AML Cells
por: Smirnova, Tatiana, et al.
Publicado: (2021)

Evolutionary implications of SARS-CoV-2 vaccination for the future design of vaccination strategies
por: Rouzine, Igor M., et al.
Publicado: (2023)

Removing constraints to sustainable food production: new ways to exploit secondary metabolism from companion planting and GM
por: Pickett, John A, et al.
Publicado: (2019)

Pivotal Roles of GM-CSF in Autoimmunity and Inflammation
por: Shiomi, Aoi, et al.
Publicado: (2015)

A Review of GM-CSF Therapy in Sepsis
por: Mathias, Brittany, et al.
Publicado: (2015)

The efficacy and safety of targeting GM-CSF in arthritis
por: Bykerk, Vivian P
Publicado: (2020)

GM-CSF: Orchestrating the Pulmonary Response to Infection
por: McCormick, Thomas S., et al.
Publicado: (2022)

Role of GM-CSF in lung balance and disease
por: Chen, Yingzi, et al.
Publicado: (2023)

GM-CSF improves the immune response to the diphtheria-component in a multivalent vaccine
por: Grasse, Marco, et al.
Publicado: (2018)

GM‐CSF is key in the efficacy of vaccine‐induced reduction of Helicobacter pylori infection
por: Vaillant, Laurie, et al.
Publicado: (2022)

Loss of GM-CSF-dependent instruction of alveolar macrophages in COVID-19 provides a rationale for inhaled GM-CSF treatment
por: Bosteels, Cedric, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_jud77qodhg8k27sbt6o3nbnh36